U.S. Biotech Stock News

Crown Castle (CCI) just put out its third-quarter results, delivering an earnings beat and raising its annual site rental revenue forecast. The company’s updated guidance points to solid demand for its tower infrastructure, especially as investment in 5G networks continues. See our latest analysis for Crown Castle. Crown Castle’s share price bounced back modestly after its upbeat Q3 earnings and the declared dividend, but recent momentum has been lukewarm, with a 30-day share price return of...

Between July and September 2025, Crown Holdings repurchased 1,097,904 shares for US$104.96 million, completing its total buyback of 5,701,011 shares, or 4.86% of shares outstanding, under the program announced in July 2024. This buyback coincided with strong Q2 2025 results and raised guidance, highlighting Crown Holdings’ confidence in its operational performance and cash flow generation. We'll look at how Crown’s solid earnings growth and major share repurchase influence its investment...

MarketAxess Holdings (MKTX) has been on investors’ radar lately as its stock performance stands in contrast to broader market trends. The company’s shares are down over the past month, which has sparked questions about underlying value and future direction. See our latest analysis for MarketAxess Holdings. MarketAxess Holdings’ share price has steadily lost ground this year, with a year-to-date price return of -25.76%. The total shareholder return for the past 12 months is even weaker at...

National Health Investors, Inc. reported its third-quarter 2025 results, with revenue rising to US$89.85 million and net income increasing to US$32.86 million, compared to the same period last year. The company also announced a quarterly dividend of US$0.92 per share, highlighting its ongoing focus on returning value to shareholders. With higher quarterly net income pointing to ongoing profitability, we'll explore how these results may reshape National Health Investors' investment...

Arrow Electronics released its third quarter results, revealing higher sales and net income compared to last year, along with updated guidance for the next quarter. These updates often matter to investors, as they highlight current performance and management expectations moving forward. See our latest analysis for Arrow Electronics. Arrow Electronics’ updated guidance and stronger quarterly numbers caught some attention, but the momentum in its share price has been less inspiring lately, with...

A week ago, Expeditors International of Washington, Inc. ( NYSE:EXPD ) came out with a strong set of quarterly numbers...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

ABM Industries (ABM) has announced two key developments: the introduction of a universal aviation access ramp in partnership with Portaramp, and the appointment of Barry Hytinen to its Board of Directors. Investors are weighing the strategic implications. See our latest analysis for ABM Industries. Even with these forward-looking moves, ABM Industries’ 1-year total shareholder return stands at -25.7%, reflecting both sector headwinds and a cautious tone in the market. However, looking further...

In late October 2025, Invitation Homes Inc. reported its third quarter and nine-month results, showing increases in sales, revenue, and net income compared to the prior year, and announced a share repurchase program authorizing up to US$500 million in buybacks. The combination of higher earnings and a sizable buyback reflects management’s confidence in the company’s performance and future outlook, drawing investor attention to its ongoing growth initiatives. To explore this further, we will...

Globus Medical (GMED) shares got a boost after management raised full-year financial guidance following strong Q3 results. Revenue and earnings outpaced analyst expectations, with broad demand and acquisition benefits fueling the company's momentum. See our latest analysis for Globus Medical. After a surge in optimism from raised guidance and a blowout quarter, Globus Medical’s share price has soared, jumping nearly 36% in a single day and over 38% in the past month. While momentum is clearly...

Wondering if Booking Holdings is a bargain or a splurge? You are not alone, especially with so many investors hunting for value in a high-flying sector. Although the stock dipped 2.7% over the past week and is down 4.9% for the month, Booking Holdings is still up 148.6% over the last 3 years and 144.1% across 5 years, hinting at long-term growth potential. Several analysts and outlets have recently spotlighted the company's ongoing global expansion and increasing travel demand, which may be...

One of the biggest stories of last week was how Backblaze, Inc. ( NASDAQ:BLZE ) shares plunged 44% in the week since...

Pitney Bowes recently reported third quarter results showing a return to profitability, declared a quarterly dividend of US$0.09 per share, and completed a buyback program, repurchasing 25,744,283 shares for US$279.77 million as announced earlier this year. These actions reflect both improved financial performance and a significant return of capital to shareholders, even as the company guided revenue toward the lower end of its annual forecast. We’ll explore how Pitney Bowes’ completion of a...

ScanSource, Inc. ( NASDAQ:SCSC ), might not be a large cap stock, but it saw significant share price movement during...

In the past week, Canadian Solar Inc. experienced a significant boost in investor interest, attributed to increasing global energy demand spurred by the expansion of artificial intelligence infrastructure and data centers. This surge highlights the growing importance of sustainable energy providers as AI-driven data centers require considerable power, prompting a renewed focus on renewable energy solutions like those offered by Canadian Solar. We’ll explore how the increased demand from...

AptarGroup (ATR) just released its third quarter results, revealing healthy year-over-year gains in both sales and net income. Stronger earnings per share stood out, giving investors a bit more to consider this quarter. See our latest analysis for AptarGroup. Beyond solid earnings, AptarGroup’s recent buyback update added to the mix, but stronger quarterly results have been the real driver. Even so, shares are still down sharply, with a 1-year total shareholder return of -33%. This reinforces...

Cheniere Energy recently reported third-quarter 2025 results, announcing US$4.44 billion in revenue, US$1.05 billion in net income, and raising its quarterly dividend by over 10% to US$0.555 per share, payable in November 2025. In addition, the company completed a major tranche of its long-term share buyback program, repurchasing more than 4.3 million shares for over US$1 billion during the quarter and marking significant progress on shareholder capital returns since 2019. We'll explore how...

Crescent Energy reported its third quarter and nine-month earnings for the period ended September 30, 2025, with quarterly revenue of US$866.58 million and a reduced net loss compared to the year prior. An important insight is the significant improvement in year-to-date net income and earnings per share, reflecting stronger ongoing business performance for Crescent Energy. With Crescent Energy's substantial year-to-date earnings growth, we'll explore the implications for its long-term...

AnaptysBio (ANAB) shares have caught investors' attention as the company’s stock delivered an impressive run recently, gaining nearly 25% over the past month. This performance puts a spotlight on AnaptysBio’s valuation and future prospects. See our latest analysis for AnaptysBio. AnaptysBio’s stellar momentum this year is hard to ignore, with a 196.78% year-to-date share price return and a brisk 88.54% surge over the past 90 days. These results reflect renewed optimism among investors. While...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

On October 27, 2025, Quest Diagnostics announced that two of its blood-based tests for identifying Alzheimer's disease pathology were found to be highly accurate, with 91% sensitivity and specificity reported in a peer-reviewed study published in Neurology® Clinical Practice. This validation suggests Quest's new tests could potentially confirm Alzheimer's diagnoses without the need for traditional follow-up scans or cerebrospinal fluid testing, indicating a shift toward easier, less invasive...

Schneider National just released its third quarter results. The report shows higher sales year-over-year, but net income and earnings per share are both lower than last year. Investors took note of the revenue growth along with lower profitability. See our latest analysis for Schneider National. After announcing increased sales but lower profits for the quarter, Schneider National’s share price saw a small bounce, rising 2.66% in a day and 6.46% over the last week. Still, bigger picture...

VVDN Technologies announced it has signed a Memorandum of Understanding with Mobileye to localize and deliver advanced driver assistance systems (ADAS) technologies for India’s automotive sector, combining Mobileye’s global expertise with VVDN’s local production and engineering capabilities. This partnership enables Indian automakers greater access to customizable ADAS solutions tailored for domestic and export markets, aligning with rising safety standards and government "Made-in-India"...

Knight-Swift Transportation Holdings (KNX) shares have seen some movement lately, and investors are watching closely to see how the company’s recent performance lines up with the broader transportation sector. The stock’s year-to-date return remains in focus. See our latest analysis for Knight-Swift Transportation Holdings. After a tough start to the year, Knight-Swift’s 1-day share price return of 4.47% stands out as an encouraging sign. Year-to-date share price return remains down at...